Cosmax Nbt Past Earnings Performance
Past criteria checks 0/6
Cosmax Nbt has been growing earnings at an average annual rate of 0.7%, while the Personal Products industry saw earnings growing at 8% annually. Revenues have been growing at an average rate of 10.1% per year.
Key information
0.7%
Earnings growth rate
0.7%
EPS growth rate
Personal Products Industry Growth | 3.8% |
Revenue growth rate | 10.1% |
Return on equity | -21.8% |
Net Margin | -2.8% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Cosmax Nbt (KOSDAQ:222040) Takes On Some Risk With Its Use Of Debt
Aug 06Cosmax Nbt, Inc. (KOSDAQ:222040) Looks Inexpensive But Perhaps Not Attractive Enough
Jun 26Is Cosmax Nbt, Inc. (KOSDAQ:222040) Trading At A 48% Discount?
May 21Little Excitement Around Cosmax Nbt, Inc.'s (KOSDAQ:222040) Revenues As Shares Take 28% Pounding
Mar 19Here's Why Cosmax Nbt (KOSDAQ:222040) Is Weighed Down By Its Debt Load
Mar 11Cosmax Nbt (KOSDAQ:222040) Has Debt But No Earnings; Should You Worry?
Apr 06What Is The Ownership Structure Like For Cosmax Nbt, Inc. (KOSDAQ:222040)?
Mar 01Cosmax Nbt (KOSDAQ:222040) Share Prices Have Dropped 76% In The Last Five Years
Feb 02Should You Think About Buying Cosmax Nbt, Inc. (KOSDAQ:222040) Now?
Jan 04Is Cosmax Nbt (KOSDAQ:222040) Using Debt In A Risky Way?
Dec 09Is Cosmax Nbt, Inc.'s (KOSDAQ:222040) Shareholder Ownership Skewed Towards Insiders?
Nov 18Revenue & Expenses Breakdown
How Cosmax Nbt makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 323,028 | -9,023 | 33,310 | 0 |
31 Mar 24 | 324,253 | -10,119 | 33,070 | 0 |
31 Dec 23 | 333,631 | -6,493 | 33,744 | 0 |
30 Sep 23 | 326,835 | -16,522 | 33,614 | 0 |
30 Jun 23 | 319,869 | -17,752 | 32,421 | 0 |
31 Mar 23 | 330,026 | -15,653 | 32,730 | 0 |
31 Dec 22 | 328,207 | -13,070 | 33,008 | 0 |
30 Sep 22 | 326,015 | -2,285 | 31,667 | 0 |
30 Jun 22 | 309,819 | -3,601 | 30,260 | 0 |
31 Mar 22 | 298,331 | -5,800 | 29,816 | 0 |
31 Dec 21 | 289,347 | -6,393 | 28,208 | 0 |
30 Sep 21 | 274,288 | -10,784 | 26,373 | 0 |
30 Jun 21 | 283,188 | -9,257 | 26,349 | 0 |
31 Mar 21 | 275,415 | -7,972 | 24,399 | 0 |
31 Dec 20 | 266,791 | -12,106 | 23,819 | 0 |
30 Sep 20 | 255,972 | -17,637 | 26,346 | 0 |
30 Jun 20 | 225,577 | -22,869 | 25,820 | 0 |
31 Mar 20 | 202,281 | -23,653 | 25,559 | 0 |
31 Dec 19 | 194,269 | -17,752 | 24,562 | 0 |
30 Sep 19 | 209,704 | -3,181 | 22,516 | 0 |
30 Jun 19 | 216,593 | 4,130 | 22,106 | 0 |
31 Mar 19 | 212,015 | 6,085 | 23,662 | 0 |
31 Dec 18 | 201,729 | 7,618 | 25,290 | 0 |
30 Sep 18 | 179,466 | 5,416 | 25,909 | 0 |
30 Jun 18 | 165,093 | 8,043 | 27,170 | 0 |
31 Mar 18 | 151,518 | 7,971 | 26,155 | 0 |
31 Dec 17 | 136,351 | 6,270 | 24,455 | 0 |
30 Sep 17 | 124,023 | 10,062 | 22,724 | 0 |
30 Jun 17 | 120,000 | 10,971 | 20,518 | 0 |
31 Mar 17 | 121,090 | 14,574 | 18,479 | 0 |
31 Dec 16 | 120,781 | 17,213 | 16,966 | 0 |
30 Sep 16 | 115,911 | 14,309 | 15,287 | 17 |
30 Jun 16 | 102,103 | 12,799 | 12,739 | 17 |
31 Mar 16 | 88,737 | 10,623 | 10,803 | 18 |
31 Dec 15 | 77,516 | 8,570 | 8,853 | 27 |
30 Sep 15 | 69,264 | 7,242 | 7,331 | 12 |
30 Jun 15 | 59,959 | 5,058 | 6,460 | 21 |
31 Mar 15 | 51,746 | 3,202 | 5,864 | 22 |
31 Dec 14 | 46,914 | 2,218 | 5,519 | 15 |
31 Dec 13 | 39,207 | 2,060 | 4,554 | 0 |
Quality Earnings: A222040 is currently unprofitable.
Growing Profit Margin: A222040 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A222040 is unprofitable, but has reduced losses over the past 5 years at a rate of 0.7% per year.
Accelerating Growth: Unable to compare A222040's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A222040 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (23.5%).
Return on Equity
High ROE: A222040 has a negative Return on Equity (-21.84%), as it is currently unprofitable.